Selected research
Market Structure
Global Imipenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Imipenem market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Imipenem include Sun Pharmaceutical Industries, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical, Savior Lifetec, HISUN Pharmaceutical and HISOAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Imipenem market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Imipenem and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Imipenem sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Imipenem market size, projected growth trends, production technologies, key applications, and end-use industries.
Imipenem Segment by Company
Sun Pharmaceutical Industries
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
Savior Lifetec
HISUN Pharmaceutical
HISOAR
Imipenem Segment by Type
Sterile Type
Non-sterile Type
Imipenem Segment by Application
Injection
Other
Imipenem Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Imipenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Imipenem and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Imipenem.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Imipenem market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imipenem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Imipenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Imipenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sterile Type
- Non-sterile Type
Applications
- Injection
- Other
Companies covered
- Sun Pharmaceutical Industries
- Haibin Pharmaceutical
- Jiangxi Fushine Pharmaceutical
- Savior Lifetec
- HISUN Pharmaceutical
- HISOAR
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Imipenem Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Imipenem Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Imipenem Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Imipenem Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Imipenem Market Dynamics
- 2.1 Imipenem Industry Trends
- 2.2 Imipenem Industry Drivers
- 2.3 Imipenem Industry Opportunities and Challenges
- 2.4 Imipenem Industry Restraints
3 Imipenem Market by Manufacturers
- 3.1 Global Imipenem Revenue by Manufacturers (2021-2026)
- 3.2 Global Imipenem Sales by Manufacturers (2021-2026)
- 3.3 Global Imipenem Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Imipenem Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Imipenem Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Imipenem Manufacturers, Product Type & Application
- 3.7 Global Imipenem Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Imipenem Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Imipenem Players Market Share by Revenue in 2025
- 3.8.3 2025 Imipenem Tier 1, Tier 2, and Tier 3
4 Imipenem Market by Type
- 4.1 Imipenem Type Introduction
- 4.1.1 Sterile Type
- 4.1.2 Non-sterile Type
- 4.2 Global Imipenem Sales by Type
- 4.2.1 Global Imipenem Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Imipenem Sales by Type (2021-2032)
- 4.2.3 Global Imipenem Sales Market Share by Type (2021-2032)
- 4.3 Global Imipenem Revenue by Type
- 4.3.1 Global Imipenem Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Imipenem Revenue by Type (2021-2032)
- 4.3.3 Global Imipenem Revenue Market Share by Type (2021-2032)
5 Imipenem Market by Application
- 5.1 Imipenem Application Introduction
- 5.1.1 Injection
- 5.1.2 Other
- 5.2 Global Imipenem Sales by Application
- 5.2.1 Global Imipenem Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Imipenem Sales by Application (2021-2032)
- 5.2.3 Global Imipenem Sales Market Share by Application (2021-2032)
- 5.3 Global Imipenem Revenue by Application
- 5.3.1 Global Imipenem Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Imipenem Revenue by Application (2021-2032)
- 5.3.3 Global Imipenem Revenue Market Share by Application (2021-2032)
6 Global Imipenem Sales by Region
- 6.1 Global Imipenem Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Imipenem Sales by Region (2021-2032)
- 6.2.1 Global Imipenem Sales by Region (2021-2026)
- 6.2.2 Global Imipenem Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Imipenem Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Imipenem Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Imipenem Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Imipenem Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Imipenem Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Imipenem Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Imipenem Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Imipenem Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Imipenem Revenue by Region
- 7.1 Global Imipenem Revenue by Region
- 7.1.1 Global Imipenem Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Imipenem Revenue by Region (2021-2026)
- 7.1.3 Global Imipenem Revenue by Region (2027-2032)
- 7.1.4 Global Imipenem Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Imipenem Revenue (2021-2032)
- 7.2.2 North America Imipenem Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Imipenem Revenue (2021-2032)
- 7.3.2 Europe Imipenem Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Imipenem Revenue (2021-2032)
- 7.4.2 Asia-Pacific Imipenem Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Imipenem Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Imipenem Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical Industries
- 8.1.1 Sun Pharmaceutical Industries Company Information
- 8.1.2 Sun Pharmaceutical Industries Business Overview
- 8.1.3 Sun Pharmaceutical Industries Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Industries Imipenem Product Portfolio
- 8.1.5 Sun Pharmaceutical Industries Recent Developments
- 8.2 Haibin Pharmaceutical
- 8.2.1 Haibin Pharmaceutical Company Information
- 8.2.2 Haibin Pharmaceutical Business Overview
- 8.2.3 Haibin Pharmaceutical Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Haibin Pharmaceutical Imipenem Product Portfolio
- 8.2.5 Haibin Pharmaceutical Recent Developments
- 8.3 Jiangxi Fushine Pharmaceutical
- 8.3.1 Jiangxi Fushine Pharmaceutical Company Information
- 8.3.2 Jiangxi Fushine Pharmaceutical Business Overview
- 8.3.3 Jiangxi Fushine Pharmaceutical Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio
- 8.3.5 Jiangxi Fushine Pharmaceutical Recent Developments
- 8.4 Savior Lifetec
- 8.4.1 Savior Lifetec Company Information
- 8.4.2 Savior Lifetec Business Overview
- 8.4.3 Savior Lifetec Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Savior Lifetec Imipenem Product Portfolio
- 8.4.5 Savior Lifetec Recent Developments
- 8.5 HISUN Pharmaceutical
- 8.5.1 HISUN Pharmaceutical Company Information
- 8.5.2 HISUN Pharmaceutical Business Overview
- 8.5.3 HISUN Pharmaceutical Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HISUN Pharmaceutical Imipenem Product Portfolio
- 8.5.5 HISUN Pharmaceutical Recent Developments
- 8.6 HISOAR
- 8.6.1 HISOAR Company Information
- 8.6.2 HISOAR Business Overview
- 8.6.3 HISOAR Imipenem Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 HISOAR Imipenem Product Portfolio
- 8.6.5 HISOAR Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Imipenem Value Chain Analysis
- 9.1.1 Imipenem Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Imipenem Production Mode & Process
- 9.2 Imipenem Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Imipenem Distributors
- 9.2.3 Imipenem Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst